about
Highly efficient elimination of colorectal tumor-initiating cells by an EpCAM/CD3-bispecific antibody engaging human T cellsNon-small cell lung cancer cells expressing CD44 are enriched for stem cell-like propertiesPancreatic cancer stem cell markers and exosomes - the incentive pushIn vitro comparative models for canine and human breast cancersMolecular biomarkers of cancer stem/progenitor cells associated with progression, metastases, and treatment resistance of aggressive cancersOvarian cancer stem cells: Can targeted therapy lead to improved progression-free survival?Exosome platform for diagnosis and monitoring of traumatic brain injuryCD44v6 dependence of premetastatic niche preparation by exosomesCD97 promotion of gastric carcinoma lymphatic metastasis is exosome dependent.CD44v6 Monoclonal Antibody-Conjugated Gold Nanostars for Targeted Photoacoustic Imaging and Plasmonic Photothermal Therapy of Gastric Cancer Stem-like Cells.CD44 gene polymorphisms and environmental factors on oral cancer susceptibility in TaiwanInteractions of human monocytes with TMVs (tumour-derived microvesicles).Thymocyte expansion and maturation: crosstalk of CD44v6 on thymocytes and panCD44 on stroma cells.Cancer stem cell marker Musashi-1 rs2522137 genotype is associated with an increased risk of lung cancer.Targeted drug delivery in pancreatic cancerCD44 gene polymorphisms on hepatocellular carcinoma susceptibility and clinicopathologic features.CD133, Trop-2 and alpha2beta1 integrin surface receptors as markers of putative human prostate cancer stem cells.Side population is not necessary or sufficient for a cancer stem cell phenotype in glioblastoma multiforme.Mullerian inhibiting substance preferentially inhibits stem/progenitors in human ovarian cancer cell lines compared with chemotherapeuticsProtein markers of cancer-associated fibroblasts and tumor-initiating cells reveal subpopulations in freshly isolated ovarian cancer ascites.Heterodimeric bispecific single-chain variable-fragment antibodies against EpCAM and CD16 induce effective antibody-dependent cellular cytotoxicity against human carcinoma cells.Isolation and characterization of tumor cells from the ascites of ovarian cancer patients: molecular phenotype of chemoresistant ovarian tumors.Cancer stem cell radioresistance and enrichment: where frontline radiation therapy may fail in lung and esophageal cancersAldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survivalIn vitro selection of modified RNA aptamers against CD44 cancer stem cell markerIsolation, identification and expression of specific human CD133 antibodies.Identification of cancer stem cells in human gastrointestinal carcinoid and neuroendocrine tumors.Differential remodeling of extracellular matrices by breast cancer initiating cells.Regulation of stem cell plasticity: mechanisms and relevance to tissue biology and cancer.PC3 is a cell line characteristic of prostatic small cell carcinoma.High frequency of putative ovarian cancer stem cells with CD44/CK19 coexpression is associated with decreased progression-free intervals in patients with recurrent epithelial ovarian cancer.CD44 rs13347 C>T polymorphism predicts breast cancer risk and prognosis in Chinese populations.Positive association between CD44 gene rs13347 C>T polymorphism and risk of cancer in Asians: a systemic review and meta-analysisTCF7L1 Modulates Colorectal Cancer Growth by Inhibiting Expression of the Tumor-Suppressor Gene EPHB3The origin, function, and diagnostic potential of RNA within extracellular vesicles present in human biological fluids.Isolation and characterization of renal cancer stem cells from patient-derived xenograftsQuantitative Secretomic Analysis Identifies Extracellular Protein Factors That Modulate the Metastatic Phenotype of Non-Small Cell Lung Cancer.Matrix metalloproteinase-10 regulates stemness of ovarian cancer stem-like cells by activation of canonical Wnt signaling and can be a target of chemotherapy-resistant ovarian cancer.Clinical applications of mouse models for breast cancer engaging HER2/neu.CD44 and CD24 coordinate the reprogramming of nasopharyngeal carcinoma cells towards a cancer stem cell phenotype through STAT3 activation.
P2860
Q21136080-0E9C2EB2-289B-44FC-B099-8590DA4CA868Q21562142-2C8AB643-C136-488F-9541-AA2F93190C99Q26741215-8433FA02-7612-492F-BBA6-2236EE5F857BQ26752714-DE7AE36B-E111-485C-AF4A-38E9BDF1468FQ26822406-3FB369AD-8E57-40EA-83AB-794CE9305394Q26826899-5ADD517D-116B-476F-B7C2-41CB5DBEBBF6Q28246267-AB8159A5-CF7A-4A65-AF48-098C9D0FCA5FQ28568064-AF3D2887-0143-4B0F-8565-1BAD17E3F821Q30316314-C8D24B41-4D7B-41BD-98E7-86C9120470FFQ30407458-79F75BA4-F116-4D9F-A2D1-8BDB7D5716D3Q31156930-F045F4CD-F2BE-44A3-B046-A2CEB68F392AQ33355180-AA5C4254-9D47-4DBD-B98B-CDB3D5476ED3Q33507242-50D5A297-35DA-461B-946F-B45B26A0DEFCQ33560334-B002AE4D-C2E8-4800-88F0-FE9072185351Q33625651-EB9B0E61-5244-44CA-B213-881BD3168B96Q33757826-3023A645-00BB-4048-AEEE-99C16C2184A7Q33793473-76CD5C18-1965-42B7-969A-20BD580EDD44Q33852195-9F19AECC-08BF-4C19-B37E-EA600144FD05Q34279411-38C99EEE-C61D-4784-900A-A1EDB1E6D549Q34383397-E00872AC-0E93-4EEB-9DE9-E61907CAFF75Q34404833-0F7DFB63-08F0-4E5E-A8E8-967C90924068Q34442318-3373E328-5EE0-4BEF-843E-A0D0BD11DB9CQ34985594-7E288667-1811-49F3-9D67-06AAE60FFEEAQ35022205-FA5A08DF-87D0-48C8-BE1A-5085B92767E9Q35028671-DB998638-6694-42D8-B27D-1C83E506C4D4Q35052038-A3700199-9678-42E2-AD59-A17F886A104DQ35456945-B834201F-FAEE-476C-935F-8D3A5D420FC3Q35544277-F8FFD745-FB7B-44AD-BE09-44D14BA5FB12Q35939439-DBBCAFF6-1C8B-4999-A525-90C799283CEBQ36185201-7BABD25C-D99B-4250-BA0A-1E11CA62923BQ36791997-78DABBBE-7E9E-44F3-B8D4-D37F4E6D683CQ36924387-17A96096-DCEB-4FBD-BD4B-24927271E2E3Q37020135-EE690B3B-D8EA-423E-B6DA-DE9C4756E3E8Q37030861-6FDDF98C-BC29-4CA9-BBEC-EA48548976F8Q37054618-03E85462-265F-4C87-AD61-C90F20CCF48CQ37085808-C1508E90-F39B-4739-B70F-2D1165FA26FEQ37210782-F6803AB3-6391-43ED-B19B-0290E3A0E49AQ37295807-D496F417-01C3-44E4-AFC9-125B2E9C7ED7Q37607675-0FC5ACDB-EF54-469A-9FF5-2C2F6D38DED5Q37629027-05F89135-4F50-4D2A-B3B3-66DC279C47BB
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
CD44 and EpCAM: cancer-initiating cell markers.
@en
CD44 and EpCAM: cancer-initiating cell markers.
@nl
type
label
CD44 and EpCAM: cancer-initiating cell markers.
@en
CD44 and EpCAM: cancer-initiating cell markers.
@nl
prefLabel
CD44 and EpCAM: cancer-initiating cell markers.
@en
CD44 and EpCAM: cancer-initiating cell markers.
@nl
P2093
P1476
CD44 and EpCAM: cancer-initiating cell markers.
@en
P2093
Irina Nazarenko
Margot Zoeller
Markus W Buechler
Pamela Klingbeil
Rachid Marhaba
Tobias Nuebel
P304
P356
10.2174/156652408786733667
P577
2008-12-01T00:00:00Z